← Leaderboards
Nadine Norton
Mayo Clinic Jacksonville
$2,772,150
Attributed
$3,112,441
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,112,441 · 3
By mechanism
R01$2,614,804 · 2
R56$497,637 · 1
Top collaborators
- Xiaolei Xu1 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Kathryn Jean Ruddy$3,623,191
Others in their field
Other Rising Stars on “Cancer Patient”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Michael E. Roth · Public Health Institute$8,201,777
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Benjamin Rybicki · Henry Ford Health System$7,553,399
- Bhaven Mehta$7,276,100
- Luis A Cifuentes · New Mexico State University Las Cruces$7,084,640
Research focus
Cancer PatientExomeGenome Wide Association StudyRisk VariantGenesCardiotoxicityDoseGenetic StudyPhenotypeVariantMouse ModelMapsAnthracyclineCardioprotectionCardiacData SetCardiac MyocytesAfrican AmericanCardiomyopathiesClinical TrialsBreast Cancer PatientCancer Cell LineBreast Cancer Risk FactorBiobank
Grant awards (5)
Discovering aging-associated genetic modifiers and therapies for anthracycline-induced cardiotoxicity$680,583
R01 · FY2025 · HL
Individualized medicine to predict and prevent chemotherapy-related heart failure$641,876
R01 · FY2025 · HL · contact PI
Individualized medicine to predict and prevent chemotherapy-related heart failure$632,207
R01 · FY2024 · HL · contact PI
Individualized medicine to predict and prevent chemotherapy-related heart failure$660,138
R01 · FY2023 · HL · contact PI
Characterization of TRPC6 to predict and prevent chemotherapy-related heart failure$497,637
R56 · FY2022 · HL · contact PI